Cargando…
Nobiletin Attenuates Pathological Cardiac Remodeling after Myocardial Infarction via Activating PPARγ and PGC1α
MATERIALS AND METHODS: C57BL/6 mice were treated with coronary artery ligation to generate an MI model, followed by treatment for 3 weeks with NOB (50 mg/kg/d) or vehicle (50 mg/kg/d), with or without the peroxisome proliferator-activated receptor gamma (PPARγ) inhibitor T0070907 (1 mg/kg/d). Cardia...
Autores principales: | Zhou, Yufei, Yin, Ting, Shi, Mengsha, Chen, Mengli, Wu, Xiaodong, Wang, Kai, Cheang, Iokfai, Li, Yanxiu, Shang, Hongcai, Zhang, Haifeng, Li, Xinli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373512/ https://www.ncbi.nlm.nih.gov/pubmed/34422028 http://dx.doi.org/10.1155/2021/9947656 |
Ejemplares similares
-
Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ
por: Wu, Xiaodong, et al.
Publicado: (2021) -
Integrated bioinformatic analysis reveals immune molecular markers and potential drugs for diabetic cardiomyopathy
por: Guo, Qixin, et al.
Publicado: (2022) -
CHA(2)DS(2)-VASc score for in-hospital recurrence risk stratification in patients with myocardial infarction
por: Pang, Hui, et al.
Publicado: (2022) -
Prognostic Association of TERC, TERT Gene Polymorphism, and Leukocyte Telomere Length in Acute Heart Failure: A Prospective Study
por: Li, Yanxiu, et al.
Publicado: (2021) -
PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s
por: Corona, Juan Carlos, et al.
Publicado: (2014)